Edgewise Therapeutics Inc (EWTX)
SG&A Expense Growth
25.57%
Quarterly · Period ending:
EWTX SG&A Expense Growth
Latest reported25.57%period ending
Latest reported25.57%period ending
EWTX Quarterly SG&A Growth (QoQ) (0.00% → 25.57%)
Latest values, visible window
High-resolution chart · PNG
EWTX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 25.567% | |
| -7.4364% | |
| 32.0644% | |
| 3.6014% | |
| -1.6301% | |
| 0.349% | |
| 11.6931% | |
| 10.5426% | |
| 5.2132% | |
| 14.2603% | |
| 9.0364% | |
| -1.9723% | |
| -0.8236% | |
| 6.6033% | |
| 25.1603% | |
| 6.8232% | |
| 10.4538% | |
| -0.857% | |
| 16.8335% | |
| 22.9704% | |
| 73.6139% | |
| 24.2324% | |
| 197.5309% | |
| 27.3585% | |
| 13.1673% | |
| 0% |